March 31, 2026 · Form 4 insider transaction
Grayson Paul A. bought 75,000 shares of Skye Bioscience, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
The stock option vests in equal monthly installments over the one year period beginning March 31, 2026.